All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

267

Reset

267 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • AMX0035Phase 32 trials

    Amylyx Pharmaceuticals Inc. · Wolfram Syndrome, Progressive Supranuclear Palsy, PSP

  • and dexamethasonePhase 32 trials

    AstraZeneca · AL Amyloidosis

  • AnselamimabCAEL-101Phase 32 trials

    AstraZeneca · AL Amyloidosis

  • ApraglutidePhase 32 trials

    VectivBio AG · Short Bowel Syndrome (SBS), SBS Associated With Intestinal Failure (SBS-IF), Short Bowel Syndrome

  • AT-001NACA, NAC-amidPhase 32 trials

    Arctic Therapeutics · Hereditary Cystatin C Amyloid Angiopathy (HCCAA), Hemorrhage Brain, Hemorrhage Cerebral

  • AVTX-803L-FucosePhase 32 trials

    AUG Therapeutics · Leukocyte Adhesion Deficiency

  • BionetideNA-921Phase 32 trials

    Biomed Industries, Inc. · Rett Syndrome

  • BL-M11D1Phase 32 trials

    Sichuan Baili Pharmaceutical Co., Ltd. · Acute Myeloid Leukemia, Myelodysplastic Syndromes

  • Carob FlourPhase 32 trials

    Nemysis Ltd · Iron-deficiency

  • CenthaquinePMZ-2010Phase 32 trials

    Pharmazz, Inc. · Acute Respiratory Distress Syndrome (ARDS), Hypovolemic Shock

  • Clemizole HClEPX-100Phase 32 trials

    Epygenix · Dravet Syndrome, Lennox Gastaut Syndrome

  • Crofelemer forPhase 32 trials

    Napo Pharmaceuticals, Inc. · Microvillus Inclusion Disease, Congenital Disorders, Rare Diseases

  • DeramiocelCAP-1002, Allogeneic Cardiosphere-Derived CellsPhase 32 trials

    Capricor Inc. · Muscular Dystrophies, Muscular Dystrophy, Duchenne, Muscular Disorders, Atrophic

  • DersimelagonMT-7117Phase 32 trials

    Tanabe Pharma America, Inc. · EPP, XLP, Erythropoietic Protoporphyria (EPP)

  • DISC-1459Bitopertin, RO4917838Phase 32 trials

    Disc Medicine, Inc · Erythropoietic Protoporphyria, Erythropoietic Protoporphyria (EPP), X-Linked Protoporphyria (XLP)

  • DTGPhase 32 trials

    Jiangsu Aidea Pharmaceutical Group Co., Ltd. · Infection, Human Immunodeficiency Virus, HIV Infections

  • Ecopipam HydrochloridePhase 32 trials

    Emalex Biosciences Inc. · Tourette Syndrome, Tourette Disorder

  • ezetimibe FDCPhase 32 trials

    NewAmsterdam Pharma · Lipidemia, Coronary Artery Disease, Plaque, Atherosclerotic

  • FTCPhase 32 trials

    Jiangsu Aidea Pharmaceutical Group Co., Ltd. · Infection, Human Immunodeficiency Virus

  • IHATPhase 32 trials

    Nemysis Ltd · Iron-deficiency

  • LucerastatPhase 32 trials

    Idorsia Pharmaceuticals Ltd. · Fabry Disease

  • Lupin Ltd. · Myotonic Dystrophy

  • BioMarin · Achondroplasia

  • NeridronatePhase 32 trials

    Ambros Therapeutics, Inc. · Complex Regional Pain Syndrome Type I

  • NNZ-2591Phase 32 trials

    Neuren Pharmaceuticals Limited · Phelan-McDermid Syndrome

  • NTLA-2001nexiguran ziclumeranPhase 32 trials

    Intellia Therapeutics · Neuromuscular Disease, Neuromuscular Diseases (NMD), Neurodegenerative Disease

  • NucresiranALN-TTRSC04Phase 32 trials

    Alnylam Pharmaceuticals · Transthyretin Amyloidosis With Cardiomyopathy, Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy, hATTR-PN

  • piclidenosonPhase 32 trials

    Can-Fite BioPharma · Plaque Psoriasis, Lowe Syndrome

  • PORT-77Phase 32 trials

    Portal Therapeutics, Inc. · Erythropoietic Protoporphyria (EPP), X-Linked Protoporphyria (XLP), EPP2

  • RipasudilK-321Phase 32 trials

    Kowa Research Institute, Inc. · Fuchs Endothelial Corneal Dystrophy

  • RoxadustatFG-4592, ASP1517Phase 32 trials

    Astellas · Chronic Kidney Disease, Renal Anemia, Myelodysplastic Syndromes

  • RVX000222apabetalone, RVX-208Phase 32 trials

    Resverlogix Corp · Post-Acute COVID-19 Syndrome, Kidney Failure, Chronic

  • sepofarsenQR-110Phase 32 trials

    Laboratoires Thea · Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis

  • SGT-003Phase 32 trials

    Solid Biosciences Inc. · Duchenne Muscular Dystrophy, Advanced Solid Tumor

  • SPG601CodabakalnerPhase 32 trials

    Spinogenix · Fragile X Syndrome (FXS), Autism Spectrum Disorder (ASD), Fragile X Syndrome

  • STSA-1002Phase 32 trials

    Staidson (Beijing) Biopharmaceuticals Co., Ltd · Acute Respiratory Distress Syndrome (ARDS), Acute Respiratory Distress Syndrome

  • SutacimigPhase 32 trials

    Hemab ApS · Thrombasthenia, Congenital Factor VII Deficiency

  • tabelecleucelATA129, EBV-CTLsPhase 32 trials

    Pierre Fabre Medicament · Solid Organ Transplant Complications, Lymphoproliferative Disorders, Allogeneic Hematopoietic Cell Transplant

  • TAK-771Phase 32 trials

    Takeda · Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Multifocal Motor Neuropathy (MMN), Primary Immunodeficiency Diseases (PID)

  • TDFPhase 32 trials

    Merck & Co. · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis, Chronic Hepatitis B Infection

  • TQB2934Phase 32 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Multiple Myeloma, Systemic Light Chain Amyloidosis

  • VAD044 L-Tartrate gelatinEngasertib, VAD044Phase 32 trials

    Vaderis Therapeutics AG · Hereditary Hemorrhagic Telangiectasia, Hereditary Hemorrhagic Telangiectasia (HHT)

  • VGR-R01Phase 32 trials

    Shanghai Vitalgen BioPharma Co., Ltd. · Bietti Crystalline Dystrophy, Inherited Retinal Diseases

  • zeleciment basivarsenDYNE-101Phase 32 trials

    Dyne Therapeutics · Myotonic Dystrophy Type 1 (DM1), DM1, Myotonic Dystrophy

  • Zeleciment RostudirsenDYNE-251Phase 32 trials

    Dyne Therapeutics · Duchenne Muscular Dystrophy (DMD), Muscular Dystrophy, Duchenne, Muscular Dystrophy (DMD)

  • zorevunersenSTK-001Phase 32 trials

    Stoke Therapeutics, Inc · Dravet Syndrome

  • ASTX030cedazuridine + azacitidinePhase 31 trial

    Taiho Oncology, Inc. · Myelodysplastic Syndromes, Acute Myeloid Leukemia, Myelodysplastic Syndrome/Neoplasm

  • BMN 333Phase 31 trial

    BioMarin · Achondroplasia

  • CAM-101Elate Ocular, FD hPLPhase 31 trial

    Cambium Bio Limited · Dry Eye Disease, Dry Eye, Dry Eyes Chronic

  • cannabidiol as a clear that can be applied to the skinZYN002, transdermal deliveryPhase 31 trial

    Harmony Biosciences Management, Inc. · Fragile X Syndrome, Fragile X Syndrome (FXS)

NewerPage 2 of 6Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.